生物降解高分子材料具有良好的生物相容性和生物降解性而成为人们关注的药物控释材料。
Biodegradable polymers, which have many advantages such as biocompatibility and biodegradability, have been focused on as controlled drug materials.
但聚二氧六环酮的结晶度较高，不适合直接用做药物控释材料，需要与其他单体进行共聚以改善其亲水性和结晶性等性质。
Poly(p-dioxanone) has high degree of crystallinity which limited it to copolymerize with other monomers to be used as controlled drug release materials.
实验结果表明了玉米醇溶蛋白是一种良好的天然药物缓控释骨架材料。
The experimental results indicated that zein could be used as a delayed-release skeleton material.
聚乳酸作为可降解的绿色生物材料，在组织工程支架、药物控释系统等领域得到了广泛的应用。
Polylactic acid as a kind of green biodegradable material, has been applied extensively in the tissue engineering scaffolds and drug controlled release devices.
阐述了靶向型药物控释体系控制释药的原理和相关材料。
Expounding the mechanism and relative material of the drug control release in the systems for drug targeting and controlled release.
羟丙基甲基纤维素（HPMC）作为构成亲水凝胶骨架片的主要控释、缓释材料广泛用于药物的控释和缓释制剂的研究。
Hydroxypropylmethylcellulose(HPMC), as hydrophilic gel matrix, is widely applied in the study of controlled release and sustained release preparations.
该水凝胶作为可降解生物材料可用于药物控释栽体和组织工程支架。
The hydrogels are good candidates for drug controlled carriers and tissue engineering scaffolds.
因此，该类超支化聚合物材料在药物控释，基因转染和组织工程等领域具有实用价值。
Therefore, the hyperbranched polyphosphate has utility values in the fields of controlled release medicament, gene transfection, tissue engineering, etc.
本发明涉及一种控释软膏组合基质及其制备方法。该软膏含有环糊精、药物、高分子材料和增塑剂。
The invention relates to a method for preparing control-release paste medium, comprising cyclodextrin, drug, macromolecule and elasticizer.
本发明涉及一种控释软膏组合基质及其制备方法。该软膏含有环糊精、药物、高分子材料和增塑剂。
The invention relates to a method for preparing control-release paste medium, comprising cyclodextrin, drug, macromolecule and elasticizer.
应用推荐